The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats

10.1053/meta.2000.17723 ◽

2000 ◽

Vol 49 (11) ◽

pp. 1395-1399 ◽

Author(s):

Yukinori Shimoshige ◽

Kyoko Ikuma ◽

Tadashi Yamamoto ◽

Shoji Takakura ◽

Ikuo Kawamura ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Zucker Diabetic Fatty Rats

Download Full-text

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

Diabetes Care ◽

10.2337/dc05-2370 ◽

2006 ◽

Vol 29 (7) ◽

pp. 1538-1544 ◽

Author(s):

N. Hotta ◽

Y. Akanuma ◽

R. Kawamori ◽

K. Matsuoka ◽

Y. Oka ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Diabetes Complications ◽

Aldose Reductase Inhibitor ◽

Clinical Effects

Download Full-text

The effects of Zenarestat, an aldose reductase inhibitor, on the nerve conduction velocity in Zucker diabetic fatty rats

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)40525-8 ◽

1998 ◽

Vol 76 ◽

pp. 101

Author(s):

Yukinori Shimoshige ◽

Kyoko Ikuma ◽

Tadashi Yamamoto ◽

Shoji Takakura ◽

Ikuo Kawamura ◽

...

Keyword(s):

Conduction Velocity ◽

Aldose Reductase ◽

Nerve Conduction ◽

Reductase Inhibitor ◽

Nerve Conduction Velocity ◽

Aldose Reductase Inhibitor ◽

Zucker Diabetic Fatty Rats

Download Full-text

Effect of an Aldose Reductase Inhibitor on Diabetic Peripheral Neuropathy

Archives of Neurology ◽

10.1001/archneur.1981.00510020091017 ◽

1981 ◽

Vol 38 (2) ◽

pp. 133 ◽

Author(s):

Antonio Culebras

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor

Download Full-text

Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat

Diabetic Medicine ◽

10.1111/j.1464-5491.2008.02490.x ◽

2008 ◽

Vol 25 (7) ◽

pp. 818-825 ◽

Author(s):

N Hotta ◽

R. Kawamori ◽

Y. Atsumi ◽

M. Baba ◽

H. Kishikawa ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Term Treatment ◽

Aldose Reductase Inhibitor ◽

Long Term Treatment

Download Full-text

Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months

Journal of Diabetes and its Complications ◽

10.1016/1056-8727(92)90023-e ◽

1992 ◽

Vol 6 (2) ◽

pp. 123-130 ◽

Author(s):

Göran Sundkvist ◽

Frank M. Armstrong ◽

Jean E. Bradbury ◽

Caroline Chaplin ◽

Stuart H. Ellis ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Autonomic Nerve ◽

Diabetic Patients ◽

Nerve Function ◽

Autonomic Nerve Function

Download Full-text

Diabetic Peripheral Neuropathy: Effect of An Aldose Reductase Inhibitor

Clinical Science ◽

10.1042/cs065019pb ◽

1983 ◽

Vol 65 (3) ◽

pp. 19P-20P

Author(s):

I.G. Lewin ◽

I.A.D. O'Brien ◽

M.H. Morgan ◽

R.J.M. Corrall

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor

Download Full-text

Clinical and Neurophysiological Studies of Aldose Reductase Inhibitor Ponalrestat in Chronic Symptomatic Diabetic Peripheral Neuropathy

Diabetes ◽

10.2337/diab.40.1.129 ◽

1991 ◽

Vol 40 (1) ◽

pp. 129-133 ◽

Author(s):

C. M. Florkowski ◽

B. R. Rowe ◽

S. Nightingale ◽

T. C. Harvey ◽

A. H. Barnett

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Neurophysiological Studies

Download Full-text

Long-term treatment of subclinical diabetic peripheral neuropathy with aldose reductase inhibitor

Electroencephalography and Clinical Neurophysiology ◽

10.1016/0013-4694(93)90956-v ◽

1993 ◽

Vol 87 (2) ◽

pp. S29

Author(s):

F.P. Serra ◽

C. Canale ◽

G. Nolfe ◽

V. Palma ◽

F. Rotondi ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Term Treatment ◽

Aldose Reductase Inhibitor ◽

Long Term Treatment

Download Full-text

Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy

Diabetes ◽

10.2337/diabetes.40.1.129 ◽

1991 ◽

Vol 40 (1) ◽

pp. 129-133 ◽

Author(s):

C. M. Florkowski ◽

B. R. Rowe ◽

S. Nightingale ◽

T. C. Harvey ◽

A. H. Barnett

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Neurophysiological Studies

Download Full-text

Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor

The American Journal of Medicine ◽

10.1016/0002-9343(85)90505-4 ◽

1985 ◽

Vol 79 (5) ◽

pp. 13-17 ◽

Author(s):

Douglas A. Greene ◽

Sarah A. Lattimer

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Recent Advances

Download Full-text